BrainMD Brain & Memory Power Boost has not been shown in a completed clinical trial to prevent or treat memory loss. Evidence for its individual ingredients is conflicting, limited, or negative, so concerning memory changes deserve medical evaluation first. The supplement combines six substances marketed for brain health. An ingredient-level study may suggest a possibility, but it cannot establish that the finished blend produces the same result.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does BrainMD sell and claim?
- Does phosphatidylserine improve memory?
- What does the evidence say about ginkgo and huperzine A?
- Who should be especially cautious?
- When should memory loss be evaluated?
What does BrainMD sell and claim?
BrainMD describes Brain & memory Power Boost as a dietary supplement containing phosphatidylserine, acetyl-L-carnitine, alpha-lipoic acid, ginkgo, huperzine A, and NAC. The company directs adults to take four capsules daily with food, according to the BrainMD product page. The company's "improve memory in 12 weeks" explanation refers to research using 300 milligrams of phosphatidylserine per day.
It does not document a completed trial of the six-ingredient product. That distinction matters. Researchers testing one ingredient at a specific dose do not automatically validate a mixture containing that ingredient alongside five others.
Does phosphatidylserine improve memory?
The evidence is conflicting. A 2013 pilot study followed 30 adults ages 50 to 90 who had memory complaints. Their test scores improved after 12 weeks of 300 milligrams of soy phosphatidylserine daily. However, that study had no placebo group and only a small number of participants.
Practice with the tests, chance, or other changes could explain some or all of the improvement. A larger randomized trial produced a less encouraging result. Among 120 older adults with age-associated memory impairment, neither 300 nor 600 milligrams daily provided a significant memory or cognitive advantage over placebo after six or 12 weeks, as reported in the Journal of Clinical Biochemistry and Nutrition study. These results do not prove that phosphatidylserine never helps anyone. They do mean the available findings cannot support a confident claim that it improves memory—or that BrainMD's complete blend does.
What does the evidence say about ginkgo and huperzine A?
Ginkgo has not delivered the hoped-for dementia-prevention benefit in a major long-term trial. The NIH-funded GEM trial included more than 3,000 adults ages 75 and older. After a median of six years, ginkgo did not reduce dementia or Alzheimer's incidence compared with placebo, according to the National Center for Complementary and Integrative Health. Evidence for huperzine A is also uncertain.
A 2013 systematic review covered 20 Alzheimer's trials with 1,823 participants and found improvements on cognitive scores. However, reviewers judged most trials to have a high risk of bias, which weakens confidence in the results. Neither body of research establishes that BrainMD's multi-ingredient supplement treats memory loss. A prevention trial also asks a different question from whether a product temporarily changes a test score in someone who already has symptoms.
Who should be especially cautious?
The National Institute on Aging states that no vitamin or supplement has been proven to prevent Alzheimer's in people. Untested supplements may also have uncertain safety or effectiveness and can interact with medicines. BrainMD advises against using this product during pregnancy or lactation.
It also cautions people taking anticoagulants or managing heart disease. Before taking the supplement, show a clinician or pharmacist the complete ingredient list, especially if the person with memory concerns: Review the full blend rather than evaluating one ingredient in isolation. Multiple ingredients create more opportunities for interactions or overlapping effects.
- Takes prescription medicines or several over-the-counter products
- Uses an anticoagulant
- Is being treated for heart disease
- Is pregnant or breastfeeding
- Has experienced new or worsening cognitive symptoms
When should memory loss be evaluated?
Occasional forgetfulness does not by itself establish dementia. However, memory problems can arise from mild cognitive impairment, dementia, or other causes, and a supplement cannot identify which explanation applies.
The National Institute on Aging's guidance on memory problems highlights functional changes that deserve attention. Arrange an evaluation when memory difficulty interferes with tasks such as: Bring a current medication and supplement list to the appointment, along with concrete examples of what changed and when. That information can help the clinician assess the cause before another supplement complicates the picture.
- Driving safely
- Using the telephone
- Finding the way home
